Free Trial
NASDAQ:JYNT

Joint (JYNT) Stock Price, News & Analysis

Joint logo
$11.60 -0.24 (-2.03%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$11.57 -0.03 (-0.26%)
As of 07/11/2025 05:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Joint Stock (NASDAQ:JYNT)

Key Stats

Today's Range
$11.32
$11.79
50-Day Range
$9.81
$12.51
52-Week Range
$9.58
$15.32
Volume
26,180 shs
Average Volume
55,003 shs
Market Capitalization
$177.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.50
Consensus Rating
Buy

Company Overview

Joint Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
69th Percentile Overall Score

JYNT MarketRank™: 

Joint scored higher than 69% of companies evaluated by MarketBeat, and ranked 432nd out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Joint has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Joint has only been the subject of 1 research reports in the past 90 days.

  • Read more about Joint's stock forecast and price target.
  • Earnings Growth

    Earnings for Joint are expected to grow by 381.82% in the coming year, from $0.11 to $0.53 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Joint is -20.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Joint is -20.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Joint has a P/B Ratio of 9.67. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Joint's valuation and earnings.
  • Percentage of Shares Shorted

    3.82% of the float of Joint has been sold short.
  • Short Interest Ratio / Days to Cover

    Joint has a short interest ratio ("days to cover") of 7.7.
  • Change versus previous month

    Short interest in Joint has recently increased by 34.49%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Joint does not currently pay a dividend.

  • Dividend Growth

    Joint does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.82% of the float of Joint has been sold short.
  • Short Interest Ratio / Days to Cover

    Joint has a short interest ratio ("days to cover") of 7.7.
  • Change versus previous month

    Short interest in Joint has recently increased by 34.49%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Joint has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Joint this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Joint insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    27.90% of the stock of Joint is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    76.88% of the stock of Joint is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Joint's insider trading history.
Receive JYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter.

JYNT Stock News Headlines

Your blueprint for crypto wealth
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
JYNT - The Joint Corp Key Metrics - Morningstar
See More Headlines

JYNT Stock Analysis - Frequently Asked Questions

Joint's stock was trading at $10.63 at the beginning of 2025. Since then, JYNT shares have increased by 9.1% and is now trading at $11.60.

The Joint Corp. (NASDAQ:JYNT) released its quarterly earnings results on Thursday, May, 8th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by $0.01. The firm had revenue of $13.08 million for the quarter, compared to analyst estimates of $13.02 million. Joint had a positive trailing twelve-month return on equity of 1.60% and a negative net margin of 9.86%.
Read the conference call transcript
.

Joint's Board of Directors approved a stock buyback plan on Thursday, June 5th 2025, which authorizes the company to repurchase $5,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 2.7% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's board believes its shares are undervalued.

Joint (JYNT) raised $20 million in an initial public offering (IPO) on Tuesday, November 11th 2014. The company issued 3,000,000 shares at $6.50 per share. Roth Capital Partners and Feltl and Company acted as the underwriters for the IPO and Sanders Morris Harris was co-manager.

Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Joint investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
5/08/2025
Today
7/12/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - HMO
Sub-Industry
Trading
Current Symbol
NASDAQ:JYNT
CIK
1612630
Employees
320
Year Founded
N/A

Price Target and Rating

High Price Target
$16.00
Low Price Target
$15.00
Potential Upside/Downside
+33.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.58)
Trailing P/E Ratio
N/A
Forward P/E Ratio
105.45
P/E Growth
N/A
Net Income
-$8.53 million
Net Margins
-9.86%
Pretax Margin
-1.79%
Return on Equity
1.60%
Return on Assets
0.41%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.59
Quick Ratio
1.59

Sales & Book Value

Annual Sales
$51.90 million
Price / Sales
3.42
Cash Flow
$0.65 per share
Price / Cash Flow
17.75
Book Value
$1.20 per share
Price / Book
9.67

Miscellaneous

Outstanding Shares
15,300,000
Free Float
11,033,000
Market Cap
$177.48 million
Optionable
Optionable
Beta
1.49

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:JYNT) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners